EDWARDS LIFESCIENCEDWARDS LIFESCIENCEDWARDS LIFESCIENC

EDWARDS LIFESCIENC

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.64CHF
Revenue estimate
‪1.51 B‬CHF
Market capitalization
‪47.55 B‬CHF
‪1.18 B‬CHF
‪5.06 B‬CHF
‪591.80 M‬
Beta (1Y)
1.66

About Edwards Lifesciences Corporation

CEO
Bernard J. Zovighian
Headquarters
Irvine
Employees (FY)
‪19.8 K‬
Founded
1958
FIGI
BBG00C5YWSN1
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EWL is 83.181 CHF — it has increased by 1.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange EDWARDS LIFESCIENC stocks are traded under the ticker EWL.
EDWARDS LIFESCIENC is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
EWL stock is 1.83% volatile and has beta coefficient of 1.66. Check out the list of the most volatile stocks — is EDWARDS LIFESCIENC there?
EWL earnings for the last quarter are 0.54 CHF per share, whereas the estimation was 0.54 CHF resulting in a 0.42% surprise. The estimated earnings for the next quarter are 0.58 CHF per share. See more details about EDWARDS LIFESCIENC earnings.
EDWARDS LIFESCIENC revenue for the last quarter amounts to ‪1.29 B‬ CHF despite the estimated figure of ‪1.26 B‬ CHF. In the next quarter revenue is expected to reach ‪1.42 B‬ CHF.
Yes, you can track EDWARDS LIFESCIENC financials in yearly and quarterly reports right on TradingView.
EWL net income for the last quarter is ‪317.46 M‬ CHF, while the quarter before that showed ‪311.43 M‬ CHF of net income which accounts for 1.93% change. Track more EDWARDS LIFESCIENC financial stats to get the full picture.
Today EDWARDS LIFESCIENC has the market capitalization of ‪47.55 B‬, it has decreased by 3.81% over the last week.
No, EWL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EWL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EDWARDS LIFESCIENC stock right from TradingView charts — choose your broker and connect to your account.
EWL reached its all-time high on Apr 22, 2022 with the price of 119.985 CHF, and its all-time low was 61.716 CHF and was reached on Jan 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has ‪19.80 K‬ employees. See our rating of the largest employees — is EDWARDS LIFESCIENC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EDWARDS LIFESCIENC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EDWARDS LIFESCIENC stock shows the buy signal. See more of EDWARDS LIFESCIENC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EDWARDS LIFESCIENC future price: according to them, EWL price has a max estimate of 96.07 CHF and a min estimate of 65.87 CHF. Read a more detailed EDWARDS LIFESCIENC forecast: see what analysts think of EDWARDS LIFESCIENC and suggest that you do with its stocks.